We use cookies on our site to analyze traffic, enhance your experience, and provide you with tailored content.
For more information visit our privacy policy.THIS EXHIBIT HAS BEEN REDACTED AND IS THE SUBJECT OF A CONFIDENTIAL TREATMENT REQUEST WITH THE U.S. SECURITIES AND EXCHANGE COMMISSION (“SEC”). REDACTED MATERIAL IS MARKED WITH [* * *] AND HAS BEEN FILED SEPARATELY WITH THE SEC. LICENSE AND...License and Collaboration Agreement • November 7th, 2018 • Verastem, Inc. • Pharmaceutical preparations • New York
Contract Type FiledNovember 7th, 2018 Company Industry JurisdictionThis LICENSE AND COLLABORATION AGREEMENT (this “Agreement”) is made as of ___________, 2018 (the “Effective Date”), by and between VERASTEM, INC., a Delaware corporation (“Verastem”), having a place of business at 117 Kendrick Street, #500, Needham, MA 02494, USA, and CSPC PHARMACEUTICAL GROUP LIMITED, a Chinese corporation (“Licensee”), having a place of business at Suite 3206, 32/F, Central Plaza, Wanchai, Hong Kong. Verastem and Licensee are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”
LICENSE AND COLLABORATION AGREEMENT between VERASTEM, INC. and YAKULT HONSHA CO., LTD DATED June 5, 2018License and Collaboration Agreement • August 8th, 2018 • Verastem, Inc. • Pharmaceutical preparations • New York
Contract Type FiledAugust 8th, 2018 Company Industry JurisdictionThis License and Collaboration Agreement (this “Agreement”) is made as of June 5, 2018 (the “Effective Date”), by and between Verastem, Inc., a Delaware corporation (“Verastem”), having a place of business at 117 Kendrick Street, #500, Needham, MA 02494, USA, and Yakult Honsha Co., Ltd., a Japanese corporation (“Licensee”), having a place of business at 1-19 Higashi Shimbashi 1-chome, Minato-ku, Tokyo, 105-8660, Japan. Verastem and Licensee are referred to in this Agreement individually as a “Party” and collectively as the “Parties.”